The Delhi Drugs Control Department seized insulin stocks worth over Rs 20 lakh from wholesale drug firms for allegedly violating storage and regulatory norms.
The government on Sunday gave a strong push to upgradation and expansion of healthcare infrastructure, medical education and pharma sector with the Union Budget 2026-27 announcing a slew of steps, including those aimed at making India a global hub for allied healthcare professionals and biopharma manufacturing.
In an order, the government's Drugs Control Department said that the step has been taken to address reports of "acute shortage of COVID-19 management drugs due to a sudden rise in COVID-19 cases in Delhi".
A comprehensive study by AIIMS, Delhi, found no evidence linking COVID-19 vaccination to sudden deaths in young adults, emphasizing the safety of the vaccines and highlighting coronary artery disease as a leading cause of sudden death.
Delhi's drugs control department has told the Delhi high court that it has launched prosecution against Gautam Gambhir Foundation and Aam Aadmi Party MLAs, Imran Hussain and Praveen Kumar, before a court for allegedly illegally stocking and distributing Covid drugs during the infection's second wave.
The department also said there is nothing to suggest that the state authorities failed to address any shortage of COVID-19 drugs.
The Enforcement Directorate made these claims in an official statement issued by the federal agency following its raids in this case at Chennai, Madurai and Tiruchirapalli on April 9.
The Narcotics Control Bureau (NCB) on Saturday said it has arrested Jaffer Sadiq, a Tamil Nadu-based alleged dealer of narcotics, in connection with an international drugs trafficking investigation case.
Police said they have made five arrests in the incident. Those arrested have been identified as Prabhjit Singh, the main accused, Kulbir Singh, Sahib Singh, Gurjant Singh and Ninder Kaur, they said.
According to the Department of Pharmaceuticals' annual report for 2024-25, India imported medical devices worth $8.1 billion, while exports stood at $3.7 billion in the financial year 2023-24 (FY24)
Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector?
The police were also taken by surprise with what they witnessed -- a sophisticated setup for creating the synthetic drug, intense intoxicating smell inside the compound and the foreigners geared up with high-quality face masks.
The move is expected to delay the introduction of low-priced medicines in the market.
The DMK also warned of legal action against those who attempt to link Sadiq with either the party or its leaders.
In what could be the beginning of fresh troubles for Ranbaxy Laboratories, which has just managed to settle long-pending issues with the US Department of Justice after agreeing to pay a penalty of $500 million, the health ministry in India, too, has decided to initiate a probe.
The impact from NELM on the Indian pharmaceutical sector is estimated to be around Rs 6,000 crore.
Both civil and criminal action was being initiated against the hospital which was severely indicted of lapses by a probe panel in its report pertaining to the death of the seven-year-old girl, an official spokesperson said.
Delhi Chief Minister Arvind Kejriwal on Thursday said dedicated centres will be set up for the treatment of black fungus or mucormycosis cases at three city government-run hospitals.
'Not even a single rupee from the electoral bonds should be allowed to be used in the election.' 'If it is used in the election, it will taint India's electoral process itself.'
Several states and UTs including Delhi, Maharashtra, Karnataka and Telangana have decided to opt for global tenders for procurement of anti-coronavirus shots with the domestic supply falling short to meet the rising demand.
The health system is trying to ensure that it isn't caught by surprise -- the way it was last time. So, hectic preparations are on.
According to DMK, the voters are already consolidated on ideological lines, hence the impact of anti-incumbency, whether against the BJP Centre or the DMK state may not be too much, notes N Sathiya Moorthy.
The two cities finally got their act together by ramping up the testing capacity and implementing stricter quarantine norms.
The government on Thursday took a series of measures in view of the rising number of COVID-19 cases in several parts of the world, including China.
Mandatory prescription of generic names is not a complete solution. Rather, in the absence of a range of approaches, it could mean passing the choice of selecting a drug from a doctor to a pharmacist, says Chandrakant Lahariya.
Dr Rajeshwari, head of the Microbiology department at the Narayan Hrudalaya in Bengaluru tells rediff.com about the effects of NDM-1 and also the measures needed to curb the spread of this enzyme.
Amid rising cases of Covid, the Centre on Friday asked eight states including Uttar Pradesh, Tamil Nadu and Maharashtra to maintain a strict watch and take pre-emptive action in any area of concern to control any emerging spread of infection.
The virus continued to spread its tentacles to new states, including Mizoram.
Former Mumbai zonal director of the Narcotics Control Bureau Sameer Wankhede on Thursday filed an affidavit in a court in Maharashtra's Washim district, stating their family belongs to a Scheduled Caste community and has not embraced any other religion.
Legendary athlete P T Usha on Wednesday batted for bringing all competitions under National Anti-Doping Agency (NADA) and sought more focus on the field of sports medicine and science to help players recover from injuries.
The dinner Jill Biden and her husband US President Joe Biden hosted for Indian prime minister Narendra Modi, June 22, at the White House brought together, Indians and Americans from so many firmaments.
"Is there a rule of law or (a rule of) raids in Maharashtra? This is the question which comes to one's mind considering the record-break raids being conducted through Central investigating agencies," Raut wrote in the weekly column 'Rokhthok' in the Sena mouthpiece 'Saamana' of which he is the executive editor.
The transition of Class A and Class B medical device makers to the licensing regime by October 1 seems to be an uphill task with several small and medium manufacturers saying they are still awaiting the audit from the government authorities. If the licenses don't come through, either due to lack of audits or MSME units not clearing the audits, then a few thousand small-scale medical device units will face the issue of business continuity in three weeks. Class A medical devices are those with low to moderate risk to the patient or user (surgical dressings for example), while Class B medical devices refer to devices with moderate risks that require special controls (catheters for example).
While Ramdev claimed that Ayurved-based 'Coronil and Swasari' medicine have shown 100 per cent favourable results during clinical trials on COVID-19 infected patients except those on a life support system, the Ayush Ministry sought from the company detailed report on composition, testing and other data of the drugs.
Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India seeking emergency use authorisation for their COVID-19 vaccines.
After Delhi, four more states -- Gujarat, Tamil Nadu, Jammu and Kashmir and Uttarakhand - on Thursday banned the sale of Maggi noodles, as the popular instant snack came under mounting scrutiny over food safety concerns.
These self-appointed well-wishers of AMU are basically for the control or police model of university governance. They have no faith whatsoever in the democratic functioning of the universities, observes Faizan Mustafa, former dean, Faculty of Law, and Registrar, Aligarh Muslim University.
As cases of 'black fungus' among COVID-19 patients in the country rise to cross 7,000, the Centre on Thursday urged all states and union territories to declare it as a notifiable disease under the Epidemic Diseases Act to ensure mandatory surveillance to tackle the 'new challenge'.
'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'
'Any person who wants to enter this service should have a single object of serving the public irrespective of hindrances.'